All Events
The National Heart, Lung, and Blood Institute (NHLBI), in partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA), hosts Research That Heals: Partnering with Patients to Transform SCD Care on June 25-26, 2026, to discuss and...
Experts convene to explore how micro-nanoplastics and PFAS exposure across the lifespan impact heart, lung, blood, and sleep health.
This two-day hybrid workshop, co-sponsored by the National Institutes of Health (NIH) and the Health and Environmental Sciences Institute (HESI Global) will bring together experts from government, academia, industry, and other stakeholders to discuss...
The Sickle Cell Disease Advisory Committee (SCDAC) makes recommendations on research priorities conducted or supported by NHLBI. The Committee also makes recommendations about long range plans of basic, clinical, applied, health education, and...
The National Heart, Lung, and Blood Institute (NHLBI), in collaboration with the U.S. Food and Drug Administration's Center for Devices and Radiological Health (FDA/CDRH), will convene a virtual workshop focused on regulatory science approaches to...
Currently, the deadly disease pulmonary hypertension (PH) is incurable. Overall, average survival rates of patients with PH are about 86% at one year after diagnosis, 67% at three years, and 54% at five years. The average age-adjusted PH mortality...
The National Institutes of Health invite your participation as a supported speaker in a public conference titled 2026 NIH Research Conference on Sleep and the Health of Women (SHOW 2026). This three-day conference is designed to highlight recent...
National Institutes of Health
Natcher Conference Center, Ruth L. Kirschstein Auditorium
45 Center Dr.
Bethesda, MD 20894
United States
Retirement symposium honoring Dr. James R. Sellers’ contributions to myosin studies. Leading scientists in the field will be present.
NIH
10 Center Dr
Building 10, Lipsett Amphitheater
Bethesda, MD 20892
United States
The 19th annual Sickle Cell in Focus (SCiF) conference was held September 24-25 2026.
Despite progress in understanding the role of the 3Is in CVD, gaps persist in effectively translating research into practice. The integration of machine learning (ML), artificial intelligence (AI), and designer drug development into cardiovascular...
The Future Directions in Sickle Cell Disease Using Network Medicine and AI Integration workshop took place September 15–16, 2026. Attendees were invited to attend the workshop virtually via NIH VideoCast. The overarching goals of the workshop were...